More on DSGN

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (7.8 Score)

Upcoming Events

- Earnings (8/10/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Design Therapeutics Inc. (NQ:DSGN)
Delayed: 11.78 -0.28 (2.32%)
Prev. Close $12.06  
Open$12.04 
52 Wk High$ 
52 Wk Low$ 
Day High$12.06 
Day Low$11.67 
P/E N/A  
EPS$ 
Volume469,883 

Friends, Peers and Foes (?): CMPS, XENE, ANAB, HLXA, PSTX (more...)

Jul 1, 2026 06:59 AM Design Therapeutics (DSGN) Reiterated at Overweight by Cantor Fitzgerald
Jun 30, 2026 08:00 AM Design Therapeutics begins patient dosing in Phase 1 DT-818 trial
Jun 30, 2026 08:00 AM Design Therapeutics Announces Initiation of Patient Dosing in Phase 1 Multiple Ascending Dose Trial of DT-818 for Myotonic Dystrophy Type-1
Jun 11, 2026 04:41 PM Form 4 Design Therapeutics, For: Jun 09 Filed by: George Simeon
Jun 11, 2026 04:16 PM Form 4 Design Therapeutics, For: Jun 09 Filed by: Shapiro David
Jun 11, 2026 04:16 PM Form 4 Design Therapeutics, For: Jun 09 Filed by: Gover Justin D.
Jun 11, 2026 04:16 PM Form 4 Design Therapeutics, For: Jun 09 Filed by: Schmid John P.
Jun 11, 2026 04:16 PM Form 4 Design Therapeutics, For: Jun 09 Filed by: LAPPE RODNEY W
Jun 11, 2026 04:15 PM Form 4 Design Therapeutics, For: Jun 09 Filed by: Berger Heather A.
Jun 11, 2026 04:05 PM Form 8-K Design Therapeutics, For: Jun 09
View All Articles

Entities mentioned with DSGN

View All Entities